First Commercial Batches Released from Building 04

We are thrilled to share some fantastic news from the heart of our operations at Eirgen Pharma. In a landmark moment for our team and our partners, our first three commercial bulk batches have been successfully produced and released from our state-of-the-art new facility, Building 04.

This achievement is a true reflection of the coordination, dedication, and expertise demonstrated by teams across the entire organization. Building a facility from the ground up and moving into commercial production requires seamless integration between departments, and this milestone proves the strength of our collective capabilities.

Gratitude to Our Team

A sincere thank you goes out to every individual who played a role in reaching this point. Whether you were involved in the initial planning, the technical setup, or the final quality checks, your commitment has laid a rock-solid foundation for the future of this facility.

"Success is not just about the destination, but the expertise and commitment of the people who pave the road to get there."

While it takes an entire organization to reach a goal of this magnitude, we would like to highlight some of the key team members who were instrumental in this specific achievement.

Pictured (L-R): Shane Coady, Michael Comerford, Brendan Ryan, Colin Widger, Alan Butler, Aaron Dillon, Jack McCusker, and Tom Flynn.

Also contributing to this success (not pictured): Derek Power, Clodagh Dunne, and Dan Brosnan.

What Lies Ahead

As we celebrate this win, we are already looking toward the horizon. We are now entering the next phase of our growth:

• Customization: Awaiting customer-specific variations to meet diverse market needs.

• Final Delivery: Preparing for the release of finished packs to the global market.

• Expansion: Scaling operations within Building 04 to support our growing partner base.

The momentum we’ve built is palpable, and we look forward to sharing more updates as we continue to deliver excellence in pharmaceutical manufacturing.